HUTCHMED drug in colorectal cancer trial meets primary endpoint
A trial to look at the use of a drug targeting refractory metastatic colorectal cancer…
August 8, 2022 - 3 minutes
News and Trends
Dallas College gets $8.8M grant to grow biotech workforce in North Texas
Dallas College has been awarded a U.S. Economic Development Administration grant to help underserved communities…
August 8, 2022 - 5 minutes
News and Trends
Epigenic Therapeutics raises $20M for gene editing technology
Epigenic Therapeutics Co., Ltd., a Chinese biotech gene editing company, has secured $20 million in…
August 8, 2022 - 2 minutes
News and Trends
Beyond Biotech podcast 8: Biotech Growth Trust, Deep Science Ventures, Endogena Therapeutics, eureKARE
This week’s podcast guests are Laura Fletcher, head of business development and strategic partnerships at…
August 5, 2022 - 3 minutes
What's New
MoreGenmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
August 8, 2022 - 2 minutes
Allogenic immune cell therapies to be developed as three groups join forces
Three entities have joined forces to develop allogenic immune cell therapies based on a platform…
August 8, 2022 - 3 minutes
Neurocrine to conduct placebo-controlled study to investigate potential new treatment for schizophrenia
A phase 2 clinical trial for the treatment of schizophrenia has been accepted by the…
August 5, 2022 - 3 minutes
Abivax has approval granted to enroll ulcerative colitis patients in two studies
Patients with moderate to severe ulcerative colitis (UC) can now be enrolled onto two phase…
August 5, 2022 - 3 minutes
Immunis closes $10M financing round
Immunis Inc., a private U.S. biotech company developing a novel treatment for age and disease-related…
August 4, 2022 - 2 minutes
First of its kind drug, to reverse effects of cocaine intoxication, awarded grant
An enzyme that efficiently degrades and metabolizes cocaine has been given a ‘cooperative agreement grant’…
August 4, 2022 - 3 minutes
Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence
Sanofi and Innovent Biologics are to collaborate on providing medicines to patients in China with…
August 4, 2022 - 3 minutes
Deal worth $3.7B sealed as Amgen buys biopharma ChemoCentryx
A company producing drugs including TAVNEOS to treat autoimmune diseases, plus others dealing with inflammatory…
August 4, 2022 - 3 minutes
From Our Partners
View More
Sponsored
by Medpace
A toolkit for emerging biotechs: practical advice for navigating challenges and advancing clinical development
Sponsored
by WuXi Advanced Therapies
Streamlining CAR-T cell therapy manufacturing: a platform approach
Sponsored
by Precision for Medicine
Using the full potential of circulating tumor cells for oncology clinical trials
Sponsored
by Merck
You need to reach market readiness? What now?
Download our industry reports
View all our reports
